Treatment Of Antibody Claims In The U.S. After Amgen v. Sanofi

The future of antibody claiming in the United States is uncertain following the U.S. Supreme Court's May 2023 ruling in Amgen Inc. v. Sanofi, 598 U.S. 594 , a highly anticipated decision concerning...

Related Keywords

Massachusetts ,United States ,Teva Pharm ,Caley Mccarthy ,Teva Pharmaceuticals ,Amgen ,Supreme Court ,Xencor Inc ,Genentech Inc ,District Court ,Baxalta Inc ,Baxalta Incorporated ,Teva Pharmaceutical ,Eli Lilly Co ,American Intellectual Property Association ,Us Supreme Court ,Mondaq Ltd ,Amgen Inc ,Patent Trial ,Appeal Board ,Federal Circuit ,Civil Action ,Calcitonin Gene Related Peptide ,Markets ,